Home / BUSINESS / Torrent Pharmaceuticals jumps on reporting 36% rise in Q2 consolidated net profit

Torrent Pharmaceuticals jumps on reporting 36% rise in Q2 consolidated net profit

Torrent Pharmaceuticals is currently trading at Rs. 1748.45, up by 67.75 points or 4.03% from its previous closing of Rs. 1680.70 on the BSE.

The scrip opened at Rs. 1685.05 and has touched a high and low of Rs. 1753.80 and Rs. 1685.05 respectively. So far 20844 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1453.00 on 23-Jul-2019.

Last one week high and low of the scrip stood at Rs. 1753.80 and Rs. 1640.90 respectively. The current market cap of the company is Rs. 29548.92 crore.

The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 20.79% and 7.96% respectively.

Torrent Pharmaceuticals has reported a rise of 18.41% in its net profit at Rs 328 crore for the quarter ended September 30, 2019 as compared to Rs 277 crore for the same quarter in the previous year. Total income of the company increased by 9.24% at Rs 1,726 crore for Q2FY20 as compared Rs 1580 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 36.31% in its net profit at Rs 244 crore for the quarter under review as compared to Rs 179 crore for the same quarter in the previous year. Total income of the company increased by 7.09% at Rs 2,039 crore for Q2FY20 as compared Rs 1,904 crore for the corresponding quarter previous year.

Please share this news